{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:03:13Z","timestamp":1781326993746,"version":"3.54.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The risks associated with non-albuminuric chronic kidney disease (CKD) have been investigated in diabetes mellitus but not in hypertensive patients. The objective of this study was to investigate the risks associated with non-albuminuric CKD in treated hypertensive patients in the Systolic Blood Pressure Intervention Trial (SPRINT) population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Based on baseline albuminuria status (urine albumin\/creatinine ratio [UACR], \u226530 or &amp;lt;30 mg\/g) and the levels of estimated glomerular filtration rate ([eGFR], \u226560, 45\u201359, or &amp;lt;45 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>), participants were classified into six subgroups to assess the risks associated with the primary outcome and mortality. The primary composite outcome was myocardial infarction, other acute coronary syndromes, stroke, heart failure, or mortality from cardiovascular causes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During a median follow-up of 3.26 years in 8,866 hypertensive patients, there were 352 deaths and 547 participants with the primary outcome. In adjusted Cox regression analysis using non-CKD and non-albuminuria (eGFR \u226560 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> combined with UACR &amp;lt;30 mg\/g) as reference, albuminuria whether combined with CKD or not, showed significantly higher risk of both primary outcome and all-cause mortality in the total population. Whereas, non-albuminuria only combined with eGFR &amp;lt;45 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> showed significantly higher risk of both primary outcome and all-cause mortality in the intensive-therapy group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Non-albuminuric CKD did have higher risk of all-cause and CVD mortality only if the eGFR &amp;lt;45 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>. Increased albuminuria conferred higher risk of primary outcome and all-cause mortality irrespective the levels of eGFR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>, number: NCT01206062.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.977938","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T06:37:45Z","timestamp":1670395065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["CVD risk in non-albuminuric chronic kidney disease in hypertensive, non-diabetic subjects: A post-hoc analysis from SPRINT"],"prefix":"10.3389","volume":"9","author":[{"given":"Chang-Sheng","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangzi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"Bloomgarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"B1","first-page":"776","article-title":"Chronic kidney disease: detection and evaluation","volume":"96","author":"Gaitonde","year":"2017","journal-title":"Am Fam Physician."},{"key":"B2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kid Dis Nat Kid Found"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.2215\/CJN.00580111","article-title":"Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death","volume":"6","author":"Berhane","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","article-title":"Clinical significance of nonalbuminuric renal impairment in type 2 diabetes","volume":"29","author":"Penno","year":"2011","journal-title":"J Hypertens."},{"key":"B6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014","volume":"316","author":"Afkarian","year":"2016","journal-title":"Jama."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.2337\/dc15-0641","article-title":"The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes","volume":"38","author":"Thorn","year":"2015","journal-title":"Diabetes Care."},{"key":"B8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2337\/dc17-1954","article-title":"Increasing mortality in adults with diabetes and low estimated glomerular filtration rate in the absence of albuminuria","volume":"41","author":"Kramer","year":"2018","journal-title":"Diabetes Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s00125-018-4691-2","article-title":"Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicentre study","volume":"61","author":"Penno","year":"","journal-title":"Diabetologia."},{"key":"B10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2337\/dc19-1438","article-title":"Risk of rapid kidney function decline, all-cause mortality, and major cardiovascular events in nonalbuminuric chronic kidney disease in type 2 diabetes","volume":"43","author":"Buyadaa","year":"2020","journal-title":"Diabetes Care."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/dc19-2049","article-title":"The prognosis of patients with type 2 diabetes and nonalbuminuric diabetic kidney disease is not always poor: implication of the effects of coexisting macrovascular complications (JDDM 54)","volume":"43","author":"Yokoyama","year":"2020","journal-title":"Diabetes Care."},{"key":"B12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"Jama."},{"key":"B13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study","volume":"55","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis J Nat Kid Found."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/j.ajkd.2007.12.012","article-title":"Hypertension and CKD: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES), 1999\u20132004","volume":"51","author":"Rao","year":"2008","journal-title":"J Kid Dis J Nat Kidney Found"},{"key":"B15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2215\/CJN.08530815","article-title":"Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage","volume":"11","author":"Drawz","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/jamainternmed.2017.0197","article-title":"Association of intensive blood pressure control and kidney disease progression in non-diabetic patients with chronic kidney disease: a systematic review and meta-analysis","volume":"177","author":"Tsai","year":"2017","journal-title":"JAMA Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","article-title":"Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study","volume":"45","author":"Ibsen","year":"2005","journal-title":"Hypertension"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"Chronic kidney disease epidemiology collaboration. New creatinine- and cystatin C-based equations to estimate GFR without Race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Eng J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2018.02.364","article-title":"Risk of progression of non-albuminuric CKD to end-stage kidney disease in people with diabetes: the CRIC (chronic renal insufficiency cohort) study","volume":"72","author":"Koye","year":"2018","journal-title":"Am J Kidney Dis J Nat Kidney Found."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1111\/j.1523-1755.2005.09419.x","article-title":"Experience with a program for prevention of chronic renal failure in India","volume":"67","author":"Mani","year":"2005","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0272-6386(03)00405-0","article-title":"Early detection of kidney disease in community settings: the kidney early evaluation program (KEEP)","volume":"42","author":"Brown","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/HJH.0b013e328336ed09","article-title":"Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients","volume":"28","author":"Viazzi","year":"2010","journal-title":"J Hypertens."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1097\/HJH.0b013e32834adb09","article-title":"Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study","volume":"29","author":"Salles","year":"2011","journal-title":"J Hypertens."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.977938\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T06:37:48Z","timestamp":1670395068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.977938\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2022.977938"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.977938","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"article-number":"977938"}}